CPI-0610

CPI-0610 · Constellation Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CPI-0610, covering 2024-05-08 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Results: A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies [Phase 1, Phase 2]

See pricing